Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion

Core Insights - Orion Corporation has updated its estimate for the annual net sales potential of its product Nubeqa®, which has become the company's largest product, with expectations that it could exceed EUR 1 billion in the future [1][2] Sales Potential - The company estimates that the annual Nubeqa net sales, which include tablet sales to Bayer and royalties, could be realized by the end of the current decade [2] - The realization of this net sales potential is influenced by various factors, including the regulatory environment, market conditions, and product indications [2] Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a hundred years of experience, focusing on developing, manufacturing, and marketing human and veterinary pharmaceuticals [2] - In 2024, Orion's net sales amounted to EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2]